Therapeutic Evaluation Of Drops of oil of Banafsha And Tiryaq isaba Wa Shaqiqa In The Management Of Migraine Without Aura Shaqiqa

Therapeutic Evaluation Of Qatur Ravghane Banafsha And Tiryaq Isaba Wa Shaqiqa In The Management Of Migraine Without Aura Shaqiqa A Randomized Open Label Comparative Clinical Study - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/08/093854

Enrollment

Registered

2025-08-28

Start date

Unknown

Completion date

Unknown

Last updated

2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G430- Migraine without aura

Interventions

Intervention1: Qatur and Tiryaq Isaba wa Shaqiqa: Qatur Instill Ravghane Banafsha Marketed formulation of Hamdard Laboratories 2 drops in each nostril will be given to the patient on bedtime daily for

Eligibility

Inclusion criteria

Inclusion criteria: Patients of 18 to 50 years of age Patients of all sexes Clinically diagnosed patients of Migraine without aura according to ICHD criteria Patients who will give consent and are able to do follow up

Exclusion criteria

Exclusion criteria: Patients below 18 and above 50 years of age Severe Anaemic patients Patients with known mental and psychiatric disorder Having systemic disorders Patients with a history of allergies especially to any component in the study drug Pregnant and lactating women Head injury Sinusitis Brain tumors

Design outcomes

Primary

Measure	Time frame
Visual Analogue ScaleTimepoint: On Day 0,7,14,21,28	—

Secondary

Measure	Time frame
Migraine Specific Quality Of Life QuestionnaireTimepoint: On Day 0 and 28	—

Countries

India

Contacts

Public ContactAarif Baig

Hakim Syed Ziaul Hasan Government Unani Medical College and Hospital

arifanees110@gmail.com7354297786

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026